<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00678184</url>
  </required_header>
  <id_info>
    <org_study_id>MED.RES.HOS.2006.03.LP</org_study_id>
    <nct_id>NCT00678184</nct_id>
  </id_info>
  <brief_title>The Effect of Atorvastatin on Renal Function in Healthy Subjects During Normal and High Sodium Intake</brief_title>
  <official_title>The Effect of Acute HMG-CoA-Reductase Inhibition (Atorvastatin) on Renal Sodium Excretion, Renal Hemodynamics, Tubular Function and Vasoactive Hormones in Healthy Subjects During Normal and High Sodium Intake</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Regional Hospital Holstebro</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Regional Hospital Holstebro</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We wanted to test the hypothesis that acute treatment with atorvastatin changes renal sodium
      handling, renal hemodynamics, tubular function and vasoactive hormones in healthy humans
      during normal and high sodium intake.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We wanted to test the hypothesis that acute treatment with atorvastatin changes renal sodium
      handling, renal hemodynamics, tubular function and vasoactive hormones in healthy humans
      during normal and high sodium intake.

      We wanted to analyze if changes in renal hemodynamics, tubular function, hormones, blood
      pressure and HR under acute treatment with atorvastatin depends on sodium intake.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2007</start_date>
  <completion_date type="Actual">October 2007</completion_date>
  <primary_completion_date type="Actual">October 2007</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Glomerular filtration rate, clearance of sodium and lithium, fractional excretion of sodium and lithium, U-AQP-2, total sodium excretion, free water clearance</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>AVP, Ang-II, Aldosterone, ANP, BNP, PRC, BP and HR.</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">23</enrollment>
  <condition>Healthy Subjects</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Atorvastatin</intervention_name>
    <description>80 mg atorvastatin on two following days each</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age 20-50 yr

          2. BMI&lt;30

          3. Females had to use oral contraceptive treatment or IUD.

        Exclusion Criteria:

          1. Clinical signs or history of disease of the heart, lungs, kidneys, liver, brain or
             endocrine organs

          2. Abnormal laboratory blood tests (hemoglobin, sodium, potassium, albumin, creatinine,
             blood glucose, bilirubin, alanin amino transferase, alkalic phosphatase)

          3. Albuminuria or glucosuria

          4. cancer

          5. arterial hypertension

          6. alcohol abuse

          7. medical treatment, except contraceptives

          8. pregnancy or breast feeding

          9. blood donation one month before the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Erling B. Pedersen, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept. of medical reaserch, Holstebro Hospital, Denmark</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Medical Research, Holstebro Hospital</name>
      <address>
        <city>Holstebro</city>
        <zip>7500</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Research</name>
      <address>
        <city>Holstebro</city>
        <zip>7500</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>May 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 13, 2008</study_first_submitted>
  <study_first_submitted_qc>May 14, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 15, 2008</study_first_posted>
  <last_update_submitted>May 14, 2008</last_update_submitted>
  <last_update_submitted_qc>May 14, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 15, 2008</last_update_posted>
  <keyword>Atorvastatin</keyword>
  <keyword>healthy</keyword>
  <keyword>sodium excretion</keyword>
  <keyword>hemodynamics</keyword>
  <keyword>tubular function</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atorvastatin Calcium</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

